UK, US, Canada accuse Russia of hacking virus vaccine trials
Britain, the United States and Canada are accusing Russia of trying to steal information from researchers seeking a COVID-19 vaccine.
Britain, the United States and Canada are accusing Russia of trying to steal information from researchers seeking a COVID-19 vaccine.
First COVID-19 vaccine tested in US produced antibodies in all patients during trial
The experimental vaccine, developed by Fauci’s colleagues at the National Institutes of Health and Moderna Inc., will start its most important step around July 27: A 30,000-person study to prove if the shots really are strong enough to protect against the coronavirus.
The experimental vaccine, developed by Fauci’s colleagues at the National Institutes of Health and Moderna Inc., will start its most important step around July 27: A 30,000-person study to prove if the shots really are strong enough to protect against the coronavirus.
Global vaccine plan may allow rich countries to buy more
Activists warn that without stronger attempts to hold political and health leaders accountable, vaccines will be hoarded by rich countries in an unseemly race to inoculate their citizens.
Activists warn that without stronger attempts to hold political and health leaders accountable, vaccines will be hoarded by rich countries in an unseemly race to inoculate their citizens.
NIAID launches clinical vaccine trials for COVID-19 — here’s how to volunteer
NIAID aims to enroll thousands of volunteers in large-scale clinical trials intended to protect people from COVID-19.
NIAID aims to enroll thousands of volunteers in large-scale clinical trials intended to protect people from COVID-19.
Maryland-based company gets $1.6B from government to develop coronavirus vaccine
Maryland-based Novavax will receive $1.6 billion through the government's Operation Warp Speed to develop a coronavirus vaccine as early as this year, the publicly-traded company announced on Tuesday.
Maryland-based Novavax will receive $1.6 billion through the government's Operation Warp Speed to develop a coronavirus vaccine as early as this year, the publicly-traded company announced on Tuesday.
Fauci expresses doubts over potential COVID-19 vaccine efficacy in US due to anti-vaxxers
“So we have a lot of work to do because as you well know... there is a general anti-science, anti-authority, anti-vaccine feeling among some people in this country, an alarmingly large percentage of people, relatively speaking," Fauci said.
“So we have a lot of work to do because as you well know... there is a general anti-science, anti-authority, anti-vaccine feeling among some people in this country, an alarmingly large percentage of people, relatively speaking," Fauci said.
Summer may decide fate of leading shots in coronavirus vaccine race
People on six continents already are getting jabs in the arm as the race for a COVID-19 vaccine enters a defining summer, with even bigger studies poised to prove if any shot really works -- and maybe offer a reality check.
People on six continents already are getting jabs in the arm as the race for a COVID-19 vaccine enters a defining summer, with even bigger studies poised to prove if any shot really works -- and maybe offer a reality check.
Who would be the first to get a COVID-19 vaccine?
Who would be the first to get a COVID-19 vaccine? Probably people in the country where the first effective vaccine is developed.
Who would be the first to get a COVID-19 vaccine? Probably people in the country where the first effective vaccine is developed.
Poll: Half of Americans would get a COVID-19 vaccine
Health experts already worry about the whiplash if vaccine promises like President Donald Trump’s goal of a 300 million-dose stockpile by January fail. Only time and science will tell -- and the new poll shows the public is indeed skeptical.
Health experts already worry about the whiplash if vaccine promises like President Donald Trump’s goal of a 300 million-dose stockpile by January fail. Only time and science will tell -- and the new poll shows the public is indeed skeptical.
US company trials coronavirus vaccine candidate in Australia
A U.S. biotechnology company has begun injecting a coronavirus vaccine candidate into people in Australia with hopes of releasing a proven vaccine this year.
A U.S. biotechnology company has begun injecting a coronavirus vaccine candidate into people in Australia with hopes of releasing a proven vaccine this year.
Why human challenge trials for a COVID-19 vaccine are worth the risks
Vaccine human challenge trials have been used for other diseases, too, such as malaria, typhoid, and Dengue fever.
Vaccine human challenge trials have been used for other diseases, too, such as malaria, typhoid, and Dengue fever.
Johnson & Johnson to begin human trial for COVID-19 vaccine candidate in September
Human trials for the vaccine would begin by September at the latest, according to a press release.
Human trials for the vaccine would begin by September at the latest, according to a press release.
First dose to be delivered Monday in clinical trial for potential COVID-19 vaccine
The first dose of a potential coronavirus vaccine will be delivered Monday, according to a governement official.
The first dose of a potential coronavirus vaccine will be delivered Monday, according to a governement official.